Cindy Lee Grines

Q: What Schools Are Affiliated With Cindy Lee Grines

Cindy Lee Grines is affiliated with the following schools: Ohio State University, University of Michigan, Medical University of South Carolina, Wayne State University, United States Military Academy, Columbia University, University of Arkansas

Cindy Lee Grines's AcademicInfluence.com Rankings

Cindy Lee Grines

Medical

#1379

World Rank

#1711

Historical Rank

Cardiology

#103

World Rank

#105

Historical Rank

medical Degrees

Cindy Lee Grines

Philosophy

#4419

World Rank

#6921

Historical Rank

Logic

#1873

World Rank

#2732

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Cindy Lee Grines's Degrees

Doctorate Medicine Harvard University
PhD Cardiology Stanford University

Why Is Cindy Lee Grines Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Cindy Lee Grines's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. (2000) (4196)
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials (2003) (4188)
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. (2004) (2339)
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. (1993) (1997)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. (2003) (1747)
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. (2002) (1310)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D (2007) (915)
Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction (1999) (915)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D (2007) (876)
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. (2004) (833)
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review (1997) (802)
Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. (1989) (778)
Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association (2016) (742)
Intravascular Ultrasound Assessment of Lumen Size and Wall Morphology in Normal Subjects and Patients With Coronary Artery Disease (1991) (705)
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. (2001) (666)
Multiple complex coronary plaques in patients with acute myocardial infarction. (2000) (645)
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris (2002) (531)
ACCF/AHA Expert Conseusus Document (2009) (530)
Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. (2005) (514)
Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. (2004) (513)
Normal Flow (TIMI-3) Before Mechanical Reperfusion Therapy Is an Independent Determinant of Survival in Acute Myocardial Infarction: Analysis From the Primary Angioplasty in Myocardial Infarction Trials (2001) (478)
Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials (2006) (439)
SCAI clinical expert consensus statement on the classification of cardiogenic shock (2019) (419)
Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction (2003) (417)
Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. (2007) (410)
A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. (2002) (384)
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American D (2007) (381)
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. (2000) (363)
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. (1998) (346)
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. (1995) (325)
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction : In-hospital and 30-day results of the PAMI stent pilot trial (1998) (290)
Effect of reperfusion on biventricular function and survival after right ventricular infarction. (1998) (287)
Coronary Stent Restenosis in Patients Treated With Cilostazol (2005) (279)
Features and outcome of no-reflow after percutaneous coronary intervention. (1995) (279)
A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. (2003) (272)
Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. (2002) (263)
Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. (2004) (254)
Management of Acute Myocardial Infarction During the COVID-19 Pandemic (2020) (250)
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock. (2017) (249)
A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. (1997) (242)
Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. (1997) (239)
Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial Infarction. (1998) (235)
Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association. (2005) (232)
Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial. (2006) (225)
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial (2014) (221)
Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. (2003) (221)
Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. (1998) (217)
Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue (2016) (214)
A Randomized Trial of Late Reperfusion Therapy for Acute Myocardial Infarction (1992) (213)
Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. (2007) (213)
Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). (2004) (203)
Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) (201)
Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. (1999) (199)
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. (2004) (198)
Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction. (2005) (197)
Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial (2005) (190)
Detection of Lipid-Core Plaques by Intracoronary Near-Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction (2011) (189)
Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction. (2004) (187)
Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. (1997) (187)
A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial. (1998) (177)
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. (1995) (173)
A Prospective, Placebo‐Controlled, Randomized Trial of Intravenous Streptokinase and Angioplasty Versus Lone Angioplasty Therapy of Acute Myocardial Infarction (1992) (172)
Long-term outcome after primary angioplasty: report from the primary angioplasty in myocardial infarction (PAMI-I) trial. (1999) (167)
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale. (2008) (166)
Benefits and Risks of Abciximab Use in Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial (2003) (161)
Six‐Month Clinical and Angiographic Follow‐up After Direct Angioplasty for Acute Myocardial Infarction: Final Results From the Primary Angioplasty Registry (1994) (161)
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. (2002) (160)
Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). (2007) (159)
Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percutaneous intervention (a pooled analysis of the primary angioplasty in myocardial infarction trials). (2000) (156)
Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. (2003) (156)
Combining antiplatelet and anticoagulant therapies. (2009) (156)
Primary angioplasty or thrombolysis for acute myocardial infarction? (2003) (156)
Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? (2004) (154)
Predictive value of the Killip classification in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. (2001) (154)
Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited. (2005) (153)
Importance of time to reperfusion on outcomes with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). (2001) (152)
Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device (2018) (146)
Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005–2009) (2014) (144)
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. (2001) (143)
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. (2007) (143)
Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography (2014) (142)
Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. (2004) (140)
Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2011) (137)
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). (2005) (136)
Impact of treatment delays on outcomes of primary percutaneous coronary intervention for acute myocardial infarction: analysis from the CADILLAC trial. (2006) (136)
Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. (1996) (136)
Outcome in Elderly Patients Undergoing Primary Coronary Intervention for Acute Myocardial Infarction: Results From the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial (2004) (135)
Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). (1994) (134)
Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. (2007) (129)
SCAI expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista) (2016) (128)
Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. (2005) (127)
Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty--the strategy of choice. (1996) (121)
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. (1997) (119)
A randomized, placebo-controlled trial of intravenous recombinant tissue-type plasminogen activator and emergency coronary angioplasty in patients with acute myocardial infarction. (1987) (117)
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. (1995) (117)
Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. (1995) (117)
Diagnosis, management, and clinical outcome of cardiac tamponade complicating percutaneous coronary intervention. (2002) (116)
SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio‐oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista) (2016) (114)
Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction. (2006) (110)
Prognostic implications and predictors of enhanced regional wall motion of the noninfarct zone after thrombolysis and angioplasty therapy of acute myocardial infarction. The TAMI Study Groups. (1989) (110)
Impact of angina class on inhibition of platelet aggregation following clopidogrel loading in patients undergoing coronary intervention: Do we need more aggressive dosing regimens in unstable angina? (2003) (108)
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. (2010) (107)
Cost-Effectiveness of Coronary Stenting in Acute Myocardial Infarction: Results From the Stent Primary Angioplasty in Myocardial Infarction (Stent-PAMI) Trial (2001) (104)
Impact of Different Platelet Glycoprotein IIb/IIIa Receptor Inhibitors Among Diabetic Patients Undergoing Percutaneous Coronary Intervention: Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-Year Follow-Up (2002) (103)
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty. (1995) (103)
Primary angioplasty in acute myocardial infarction at hospitals with no surgery on-site (the PAMI-No SOS study) versus transfer to surgical centers for primary angioplasty. (2004) (101)
Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. (1994) (100)
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction. (2001) (100)
Comparison of outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction. (2003) (98)
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: the Early Rapid ReversAl of platelet thromboSis with intra (2009) (98)
Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial. (2007) (97)
Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction (1991) (97)
Detailed angiographic analysis of high-speed mechanical rotational atherectomy in human coronary arteries. (1993) (97)
North American Expert Review of Rotational Atherectomy. (2019) (97)
Simplified scoring system for predicting mortality after percutaneous coronary intervention. (2003) (95)
Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris. (1999) (93)
Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. (2004) (93)
Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010]). (2014) (89)
Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. (2004) (89)
A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. (1996) (88)
The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. (2003) (88)
Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions in Patients With Unstable and Stable Presentation (2003) (87)
Quality of life after balloon angioplasty or stenting for acute myocardial infarction. One-year results from the Stent-PAMI trial. (2001) (86)
Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. (2005) (86)
Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. (1998) (86)
Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. (2010) (85)
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trial. (1996) (84)
Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction (2000) (83)
Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial* (2002) (83)
Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial. (2004) (83)
Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction. (2005) (82)
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial. (2009) (80)
Utilization of catheter‐directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter‐directed thrombolysis (2015) (78)
Effect of Hospital Volume on Outcomes of Transcatheter Aortic Valve Implantation. (2015) (78)
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial). (2006) (78)
Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. (2000) (77)
Initial Findings From the North American COVID-19 Myocardial Infarction Registry (2021) (76)
Impact of mild or moderate chronic kidney disease on the frequency of restenosis: results from the PRESTO trial. (2004) (76)
Coronary embolization following balloon dilation of lipid-core plaques. (2009) (75)
Angiogenic gene therapy with adenovirus 5 fibroblast growth factor-4 (Ad5FGF-4): a new option for the treatment of coronary artery disease. (2003) (73)
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study). (2001) (71)
Antithrombotic therapy during percutaneous coronary intervention: The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy (2005) (70)
Relation of admission white blood cell count to long-term outcomes after primary coronary angioplasty for acute myocardial infarction (The Stent PAMI Trial). (2003) (70)
Comparison of outcome in patients with acute myocardial infarction aged > 75 years with that in younger patients. (1995) (70)
Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. (2006) (69)
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial). (2004) (68)
Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention. (2004) (68)
Management of acute myocardial infarction during the COVID‐19 pandemic (2020) (66)
Primary angioplasty vs. intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials (2003) (66)
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction. (2005) (65)
Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction. (1997) (65)
The year in interventional cardiology. (2004) (65)
Rapid hemodynamic improvement after reperfusion during right ventricular infarction. (1995) (64)
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. (2002) (64)
Fibrinolytic therapy: is it a treatment of the past? (2003) (62)
Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States: Influence of Hospital Volume (2015) (62)
Comparison of the prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the primary angioplasty in myocardial infarction trials. (2005) (61)
Primary coronary intervention for acute myocardial infarction. (2004) (61)
Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction. (1998) (61)
Infarct vessel status after intravenous tissue plasminogen activator and acute coronary angioplasty: prediction of clinical outcome. (1988) (59)
Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. (2003) (57)
A Prospective, Randomized Evaluation of Prophylactic Intraaortic Balloon Counterpulsation in High Risk Patients With Acute Myocardial Infarction Treated With Primary Angioplasty fn1fn1Funding for this study was provided in part by unrestricted grants from Advanced Cardiovascular Systems, Inc., Santa (1997) (57)
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial). (2005) (56)
Relationship between infarct artery location, epicardial flow, and myocardial perfusion after primary percutaneous revascularization in acute myocardial infarction. (2006) (55)
Prediction of one-year mortality among 30-day survivors after primary percutaneous coronary interventions. (2006) (54)
A pooled analysis of the effect of endovascular cooling on infarct size in patients with ST-elevation myocardial infarction. (2013) (54)
Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile. (2003) (53)
A new clinical classification for hospital prognosis of unstable angina pectoris. (1995) (52)
Predictors of success for coronary angioplasty performed for acute myocardial infarction. (1988) (51)
Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. (2004) (50)
The State of the Absorb Bioresorbable Scaffold: Consensus From an Expert Panel. (2017) (50)
Comparison of left ventricular ejection fraction and exercise capacity as predictors of two- and five-year mortality following acute myocardial infarction. (2007) (48)
Percutaneous aortic balloon valvotomy in the United States: a 13-year perspective. (2014) (48)
Analysis of target lesion length before coronary artery stenting using angiography and near-infrared spectroscopy versus angiography alone. (2012) (47)
SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease (2020) (47)
State of the art: Evaluation and prognostication of myocarditis using cardiac MRI (2019) (47)
Effect of percutaneous coronary intervention on quality of life: A consensus statement from the society for cardiovascular angiography and interventions (2013) (47)
Primary Percutaneous Coronary Intervention for Every Patient with ST-Segment Elevation Myocardial Infarction: What Stands in the Way? (2004) (46)
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. (2021) (45)
Comparative results of transluminal extraction coronary atherectomy in saphenous vein graft lesions with and without thrombus. (1995) (45)
Women in interventional cardiology: Update in percutaneous coronary intervention practice patterns and outcomes of female operators from the National Cardiovascular Data Registry® (2016) (44)
Frequency of returning to work one and six months following percutaneous coronary intervention for acute myocardial infarction. (2004) (44)
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. (1996) (44)
Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction. (2011) (44)
Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self‐expandable bioprosthetic valve (2018) (44)
A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention. Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study. (2003) (42)
Usefulness of the presence of peripheral vascular disease in predicting mortality in acute myocardial infarction patients treated with primary angioplasty (from the Primary Angioplasty in Myocardial Infarction Database). (2005) (42)
Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta‐analysis (2018) (42)
Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty. (2007) (42)
Meta-Analysis Comparing the Incidence of Infective Endocarditis Following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement. (2019) (41)
Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. (2005) (41)
Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction: Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial (2003) (41)
Success, safety, and mechanisms of failure of percutaneous coronary intervention for occlusive non-drug-eluting in-stent restenosis versus native artery total occlusion. (2005) (40)
Factors influencing myocardial salvage with primary angioplasty (1995) (40)
SCAI/ACC/AHA expert consensus document: 2014 update on percutaneous coronary intervention without on-site surgical backup. (2014) (40)
Prospective, randomized trial of prolonged intracoronary urokinase infusion for chronic total occlusions in native coronary arteries. (1996) (40)
The year in interventional cardiology. (2008) (39)
Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis (2016) (39)
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial). (2004) (39)
Off-label use of drug-eluting stents putting it in perspective. (2008) (39)
Treatment of Massive or Submassive Acute Pulmonary Embolism With Catheter-Directed Thrombolysis. (2016) (38)
Women in Medicine: Addressing the Gender Gap in Interventional Cardiology. (2018) (38)
Sex Differences in the Pursuit of Interventional Cardiology as a Subspecialty Among Cardiovascular Fellows-in-Training. (2019) (38)
North American COVID-19 ST-Segment-Elevation Myocardial Infarction (NACMI) registry: Rationale, design, and implications (2020) (38)
Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation. (2007) (37)
Poloxamer-188 as an adjunct to primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1996) (37)
PET perfusion and vasodilator function after angioplasty for acute myocardial infarction. (1997) (37)
Balloon mitral valvuloplasty in the United States: a 13-year perspective. (2014) (36)
Expert Consensus Document Accf/acr/aha/nasci/scmr 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance a Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents Writing Committee Members Expert Consensus Document Table of Contents Hundley Et Al (2010) (36)
Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction (2003) (36)
SCAI expert consensus statement-executive summary evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (2015) (36)
Peroxisome proliferator-activated receptor gamma agonists for the Prevention of Adverse events following percutaneous coronary Revascularization--results of the PPAR study. (2007) (35)
Should patients with acute myocardial infraction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in the community? The case for emergency transfer for primary percutaneous coronary intervention. (2005) (34)
Real‐world supported unprotected left main percutaneous coronary intervention with impella device; data from the USpella registry (2017) (34)
Comparison of inhospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus angiography. (2015) (34)
Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction. (1998) (33)
Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction. (2007) (33)
Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators. (2000) (32)
Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. (2012) (32)
Intracoronary fibrin-specific thrombolytic infusion facilitates percutaneous recanalization of chronic total occlusion. (2005) (32)
The functional assessment of patients with non-obstructive coronary artery disease: expert review from an international microcirculation working group. (2019) (32)
Reproducible microvascular dysfunction with dobutamine infusion in Takotsubo cardiomyopathy presenting with ST segment elevation (2006) (32)
A Random Forest Based Risk Model for Reliable and Accurate Prediction of Receipt of Transfusion in Patients Undergoing Percutaneous Coronary Intervention (2014) (31)
A systematic review of reported cases of combined transcatheter aortic and mitral valve interventions (2018) (31)
Does proximal location of culprit lesion confer worse prognosis in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction? (2006) (31)
Impact of symptoms, gender, co-morbidities, and operator volume on outcome of carotid artery stenting (from the Nationwide Inpatient Sample [2006 to 2010]). (2014) (31)
Do excimer laser angioplasty and rotational atherectomy facilitate balloon angioplasty? Implications for lesion-specific coronary intervention. (1996) (31)
Intraluminal thrombus in facilitated versus primary percutaneous coronary intervention: an angiographic substudy of the ASSENT-4 PCI (Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) trial. (2011) (31)
Effect of peripheral cardiopulmonary bypass on left ventricular size, afterload and myocardial function during elective supported coronary angioplasty. (1991) (30)
Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations. (2017) (30)
Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock. (2021) (30)
Safety and Cost-Effectiveness of Early Discharge After Primary Angioplasty in Low Risk Patients With Acute Myocardial Infarction 11Research funding for this study was provided by unrestricted grants from Advanced Cardiovascular Systems, Santa Clara, California; Mallinckrodt Medical, Inc., Saint Loui (1998) (30)
One-year survival in patients with acute myocardial infarction and a saphenous vein graft culprit treated with primary angioplasty. (2003) (30)
Acute angiographic analysis of non-ST-segment elevation acute myocardial infarction. (2004) (29)
Success, complications, and restenosis following rotational and transluminal extraction atherectomy of ostial stenoses. (1994) (29)
SCAI/ACC/AHA Expert Consensus Document: 2014 update on percutaneous coronary intervention without on-site surgical backup. (2014) (29)
Intravascular Ultrasound in Lower Extremity Peripheral Vascular Interventions (2016) (29)
Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. (2010) (29)
CORONARY ARTERY DISEASE Original Studies Expert Consensus Statement on the Use of Fractional Flow Reserve, Intravascular Ultrasound, and Optical Coherence Tomography: A Consensus Statement of the Society of Cardiovascular Angiography and Interventions (2014) (29)
Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting. (2004) (29)
Meta-Analysis of Usefulness of Percutaneous Left Ventricular Assist Devices for High-Risk Percutaneous Coronary Interventions. (2016) (28)
Coronary Atherectomy in the United States (from a Nationwide Inpatient Sample). (2016) (28)
Impact of Hospital Volume on Outcomes of Lower Extremity Endovascular Interventions (Insights from the Nationwide Inpatient Sample [2006 to 2011]). (2015) (28)
SCAI/ACC/AHA Expert Consensus Document (2014) (28)
Prospective study of extraction atherectomy in patients with acute myocardial infarction. (1996) (27)
Incidence and Survival After In-Hospital Cardiopulmonary Resuscitation in Nonelderly Adults: US Experience, 2007 to 2012 (2017) (27)
Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Cryptogenic Stroke. (2017) (27)
Low-molecular-weight heparin therapy in percutaneous coronary intervention: the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin Investigators. (2000) (27)
Are residual stenoses after excimer laser angioplasty and coronary atherectomy due to inefficient or small devices? Comparison with balloon angioplasty. (1993) (26)
Percutaneous Coronary Intervention in Patients With End-Stage Liver Disease. (2016) (26)
Is Transcatheter Aortic Valve Replacement Better Than Surgical Aortic Valve Replacement in Patients With Chronic Obstructive Pulmonary Disease? A Nationwide Inpatient Sample Analysis (2018) (26)
Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry. (1995) (26)
Incidence and predictors of early recurrent ischemia after successful percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1989) (26)
Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PCTA) (1998) (25)
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. (1996) (25)
Comparison of left ventricular function and contractile reserve after successful recanalization by thrombolysis versus rescue percutaneous transluminal coronary angioplasty for acute myocardial infarction. (1988) (25)
Mortality in patients with ST-segment elevation myocardial infarction who do not undergo reperfusion. (2012) (25)
Pre‐close technique of percutaneous closure for delayed hemostasis of large‐bore femoral sheaths (2018) (25)
One-year follow-up after primary coronary intervention for acute myocardial infarction in diabetic patients. A substudy of the STENT PAMI trial. (2001) (25)
Combination of lovastatin, enalapril, and colchicine does not prevent restenosis after percutaneous transluminal coronary angioplasty. (1995) (24)
Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. (2003) (24)
Comparison of In-Hospital Outcomes and Readmission Rates in Acute Pulmonary Embolism Between Systemic and Catheter-Directed Thrombolysis (from the National Readmission Database). (2017) (23)
Access and closure management of large bore femoral arterial access (2018) (23)
Sex Disparities in Cardiovascular Device Evaluations: Strategies for Recruitment and Retention of Female Patients in Clinical Device Trials. (2019) (22)
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial. (2003) (22)
Aggressive intervention for myocardial infarction: angioplasty, stents, and intra-aortic balloon pumping. (1996) (22)
Mechanical circulatory support for acute right ventricular failure in the setting of pulmonary embolism (2018) (21)
Local intramural heparin delivery during primary angioplasty for myocardial infarction: Results of the local PAMI pilot study (1999) (21)
Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. (2010) (21)
Meta-Analysis of Effectiveness and Safety of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Low-to-Intermediate Surgical Risk Cohort. (2019) (20)
Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy). PAMI Investigators. (1996) (20)
901-1 A Prospective, Randomized Trial Evaluating Early Discharge (Day 3) without Non-invasive Risk Stratification in Low Risk Patients with Acute Myocardial Infarction: PAMI-2 (1995) (20)
Effects of endovascular cooling on infarct size in ST‐segment elevation myocardial infarction: A patient‐level pooled analysis from randomized trials (2018) (20)
Glidewire treatment of resistant coronary occlusions. (1993) (20)
A prospective, multicenter, international randomized trial comparing four reperfusion strategies in acute myocardial infarction: Principal report of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial (2001) (19)
Optimal burr and adjunctive balloon sizing reduces the need for target artery revascularization after coronary mechanical rotational atherectomy. (1996) (19)
Clinical and Angiographic Correlates and Outcomes of Suboptimal Coronary Flow in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (2016) (19)
Usefulness of creatinine clearance in predicting early and late death after primary angioplasty for acute myocardial infarction. (2003) (19)
Primary coronary angioplasty versus thrombolysis. (1997) (19)
Detailed clinical and angiographic analysis of transluminal extraction coronary atherectomy for complex lesions in native coronary arteries. (1995) (19)
A nail in the coffin of troponin measurements after percutaneous coronary intervention. (2011) (19)
Operator and institutional volume do not affect the procedural outcome of primary angioplasty therapy (1996) (19)
Use of Impella heart pump for management of women with peripartum cardiogenic shock (2019) (18)
Deformation, longitudinal shortening, and accordion of an ion stent. (2011) (18)
Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction. (2008) (18)
Ultrasound Accelerated Thrombolysis in patients with acute pulmonary embolism: A systematic review and proportion meta-analysis. (2016) (17)
Effect of door-to-balloon time on patient mortality. (2006) (17)
Comparison of outcomes of balloon aortic valvuloplasty plus percutaneous coronary intervention versus percutaneous aortic balloon valvuloplasty alone during the same hospitalization in the United States. (2015) (17)
In-Hospital Outcomes of Atherectomy During Endovascular Lower Extremity Revascularization. (2016) (17)
Percutaneous triple-valve balloon valvuloplasty in a pregnant woman. (1991) (17)
Usefulness of adjunctive angioscopy and extraction atherectomy before stent implantation in high-risk aortocoronary saphenous vein grafts. (1995) (16)
Rescue angioplasty: does the concept need to be rescued? (2004) (16)
Comparison of effectiveness of primary angioplasty for proximal versus distal right coronary artery culprit lesion during acute myocardial infarction. (2002) (16)
Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint. (2020) (16)
Incidence and Outcomes of Heparin-Induced Thrombocytopenia in Patients Undergoing Transcatheter Aortic Valve Replacement. (2017) (15)
Postural exercise abnormalities in symptomatic patients with mitral valve prolapse. (1988) (15)
Radiation-Induced Vascular Disease—A State-of-the-Art Review (2021) (15)
A Bayesian meta-analysis comparing AngioJet thrombectomy to percutaneous coronary intervention alone in acute myocardial infarction. (2008) (15)
Approach to the patient with prior bypass surgery. (2004) (15)
Impact of Contrast Dose Reduction on Incidence of Acute Kidney Injury (AKI) Among Patients Undergoing PCI: A Modeling Study. (2016) (15)
The role of statins in reversing atherosclerosis: what the latest regression studies show. (2006) (15)
Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris. (2003) (15)
Racial and ethnic disparities in coronary, vascular, structural, and congenital heart disease (2021) (14)
A Prospective, Randomized Trial Comparing Combination Half‐Dose Tissue‐Type Plasminogen Activator and Streptokinase With Full-Dose Tissue‐Type Plasminogen Activator (1991) (14)
Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial). (2004) (14)
Computed tomographic angiographic morphology of invasively proven complex coronary plaques. (2008) (14)
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial) (2003) (14)
Frequency, determinants, and clinical implications of residual intracoronary thrombus following primary angioplasty for acute myocardial infarction. (2003) (14)
Impact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial). (2014) (14)
Meta-Analysis of Sex Disparities in In-hospital Care and Outcomes in Patients with ST-Segment Elevation Myocardial Infarction. (2021) (14)
Transcatheter aortic valve implantation in the United States: Predictors of early hospital discharge (2017) (14)
Early Real-World Experience with CoreValve Evolut PRO and R Systems for Transcatheter Aortic Valve Replacement (2019) (13)
Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery. (2013) (13)
Failure to Rescue, Hospital Volume, and In-Hospital Mortality After Transcatheter Aortic Valve Implantation. (2018) (13)
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors. (2007) (13)
Surgery or stent? The gap continues to narrow (2002) (13)
Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain (2007) (13)
The AGENT clinical trials programme (2004) (13)
Safety and effectiveness of dofetilide for conversion of atrial fibrillation and nesiritide for acute decompensation of heart failure: a report from the cardiovascular and renal advisory panel of the Food and Drug Administration. (2000) (13)
Complete versus incomplete revascularization with drug‐eluting stents for multi‐vessel disease in stable, unstable angina or non‐ST‐segment elevation myocardial infarction: A meta‐analysis (2017) (12)
Diagnosing and managing unstable angina (1994) (12)
Practical Handbook of Advanced Interventional Cardiology: Tips and Tricks (2012) (12)
Lack of relationship between the time to reperfusion and short-term mortality after primary infarct angioplasty (1998) (12)
Medical Misinformation. (2019) (12)
SCAI Expert Consensus Statement (2016) (12)
Effects of left bundle branch block on the events of the cardiac cycle. (1988) (12)
Percutaneous Coronary Interventions and Hemodynamic Support in the USA: A 5 Year Experience. (2015) (12)
Comparison of Inhospital Outcomes of Surgical Aortic Valve Replacement in Hospitals With and Without Availability of a Transcatheter Aortic Valve Implantation Program (from a Nationally Representative Database). (2015) (12)
Noninvasive prediction of residual blood flow within the risk area during acute myocardial infarction: a multicenter validation study of patients undergoing direct coronary angioplasty. (1997) (12)
Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths. (2017) (12)
Prolonged urokinase infusion for chronic total native coronary occlusions: clinical, angiographic, and treatment observations. (1995) (12)
Impact on in-hospital outcomes with drug-eluting stents versus bare-metal stents (from 665,804 procedures). (2014) (12)
Thrombolytic, antiplatelet, and antithrombotic agents. (1992) (11)
715-2 A Prospective, Randomized Trial Evaluating the Prophylactic Use of Balloon Pumping in High Risk Myocardial Infarction Patients: PAMI-2 (1995) (11)
Implications of myocardial reperfusion on survival in women versus men with acute myocardial infarction undergoing primary coronary intervention. (2013) (11)
Low- versus high-dose recombinant urokinase for the treatment of chronic saphenous vein graft occlusion. (1999) (11)
A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction. (2008) (11)
Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women (2005) (11)
Comparison of Hospital Outcome of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes Mellitus (from the Nationwide Inpatient Sample). (2017) (11)
Predictors of maintained infarct artery patency after primary angioplasty in high risk patients in PAMI-2 (1996) (11)
Comparison of the usefulness of enoxaparin versus warfarin for prevention of left ventricular mural thrombus after anterior wall acute myocardial infarction. (2015) (11)
Primary percutaneous interventions for acute myocardial infarction in octogenarians: A single‐center experience (2002) (11)
Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF. (2022) (11)
Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry). (2005) (11)
Gender‐based issues in interventional cardiology: A consensus statement from the Women in Innovations (WIN) Initiative (2010) (11)
Clinical, hemodynamic, electrocardiographic and mechanical events during nonocclusive, coronary atherectomy and comparison with balloon angioplasty. (1992) (11)
Procedural cost of new interventional devices. (1994) (11)
Comparison of Health Related Quality of Life in Transcatheter Versus Surgical Aortic Valve Replacement: A Meta-Analysis. (2019) (11)
Percutaneous Coronary Intervention: 2015 in Review. (2016) (10)
Confronting system barriers for ST- elevation MI in low and middle income countries with a focus on India (2017) (10)
Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions (2018) (10)
Usefulness of percutaneous transluminal coronary angioplasty after new device coronary interventions. (1994) (10)
Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19 (2022) (10)
Primary percutaneous coronary intervention: the deception of delay. (2013) (10)
Angioscopic plaque friability: A new risk factor for procedural complications following sephenous vein graft interventions (1996) (10)
Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial). (2003) (10)
Trends in Vascular Complications in High-Risk Patients Following Transcatheter Aortic Valve Replacement in the United States. (2017) (10)
In-Hospital Outcomes of ST-Segment Elevation Myocardial Infarction Complicated With Cardiogenic Shock at Safety-Net Hospitals in the United States (from the Nationwide Inpatient Sample). (2019) (10)
Impact of Hospital Volume on Outcomes of Endovascular Stenting for Adult Aortic Coarctation. (2015) (10)
Sex‐related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high‐risk percutaneous coronary intervention: Insight from the cVAD registry (2019) (10)
Therapeutic angiogenesis: a fantastic new adventure. (2002) (10)
Successful reversal of cardiogenic shock precipitated by saphenous vein graft distal embolization using aspiration thrombectomy. (1994) (9)
Acute PCI for ST-segment elevation myocardial infarction: is later better than never? (2005) (9)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (9)
Comparisons of the uptake and in-hospital outcomes associated with second-generation drug-eluting stents between men and women: results from the CathPCI Registry (2016) (9)
A prospective, randomized trial comparing combination half dose tPA with streptokinase to full dose tPA in acute myocardial infarction: Preliminary report (1990) (9)
Nationwide survival after inhospital cardiac arrest before and after 2010 cardiopulmonary resuscitation guidelines: 2007-2014. (2017) (9)
Palliative care referral in ST-segment elevation myocardial infarction complicated with cardiogenic shock in the United States. (2019) (9)
Sex differences in the drug-eluting stent era: do they still exist? (2012) (9)
Measurement of regional myocardial perfusion and mass by subselective hydrogen infusion and washout techniques: a validation study. (1987) (9)
Rapid bedside coronary angiography with a portable fluoroscopic imaging system. (1997) (9)
Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial). (2012) (9)
Improved Short-Term Outcomes of Primary Coronary Stenting Compared to Primary Balloon Angioplasty in Acute Myocardial Infarction at Experienced Centers: The PAMI Study Group Experience (1999) (8)
Amoxapine: a cause of toxic epidermal necrolysis? (1983) (8)
Transradial versus transfemoral percutaneous coronary intervention of left main disease: A systematic review and meta‐analysis of observational studies (2018) (8)
Coronary artery pseudoaneurysm after balloon angioplasty and intracoronary β‐radiation for in‐stent restenosis (2004) (8)
Left ventricular remodeling and systolic deterioration in acute myocardial infarction: findings from the Stent-PAMI Study. (2005) (8)
Aspiration Thrombectomy in Patients Undergoing Primary Angioplasty for ST Elevation Myocardial Infarction: An Updated Meta-Analysis. (2015) (8)
Medical Misinformation: Vet the Message! (2019) (8)
A time-to-treatment analysis in the medicine versus angiography in thrombolytic exclusion (MATE) trial. (2001) (8)
Interventional procedures in acute myocardial infarction. (2001) (8)
Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock (2020) (8)
Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient sample (2016) (8)
Etiologies and Predictors of 30-Day Readmission and In-Hospital Mortality During Primary and Readmission After Transcatheter Aortic Valve Implantation. (2016) (8)
Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry. (2019) (7)
Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnostic-related group system. (2003) (7)
Multivessel Percutaneous Coronary Interventions in the United States (2016) (7)
Transcatheter Aortic Valve Replacement: 2015 in Review. (2016) (7)
Comparison of In-Hospital Mortality, Length of Stay, Postprocedural Complications, and Cost of Single-Vessel Versus Multivessel Percutaneous Coronary Intervention in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction (from Nationwide Inpatient Sample [2006 to 2012]). (2016) (7)
How important is time to treatment with primary percutaneous coronary intervention for acute myocardial infarction? Results from the CADILLAC trial (2003) (7)
1022-103 Does Primary Angioplasty Improve the Prognosis of Patients with Diabetes and Acute Myocardial Infarction? (1995) (7)
Hospital teaching status and trascatheter aortic valve replacement outcomes in the United States: Analysis of the national inpatient sample (2017) (7)
Fractional flow-guided management in patients with acute coronary syndromes: A systematic review and meta-analysis. (2015) (7)
Working group on noncoronary cardiovascular disease and exercise in women. (1992) (7)
Reducing system delays in treatment of ST elevation myocardial infarction and confronting the challenges of late presentation in low and middle-income countries (2017) (7)
Outcome of Transcatheter Aortic Valve Implantation in Patients with Peripheral Vascular Disease. (2019) (7)
Primary angioplasty for myocardial infarction improves long-term survival: PAMI-1 follow-up (1996) (7)
Primary PTCA versus thrombolytic therapy for acute MI (2003) (7)
Effectiveness of primary angioplasty for acute myocardial infarction in patients on dialysis. (2004) (7)
“Back to the Future” for STEMI? (2020) (7)
Treating myocardial infarction: importance of early reperfusion (1994) (7)
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial). (2003) (7)
Women and Cardiology: The Value of Diversity. (2020) (7)
Comparison of Inhospital Outcomes and Hospitalization Costs of Peripheral Angioplasty and Endovascular Stenting. (2015) (6)
In vivo assesment of human coronary minimum laminil diameter with a multi-element intravascular ultrasound catheter: Comparison to quantitative cineangiography (1990) (6)
Current percutaneous treatment strategies for saphenous vein graft disease (2013) (6)
Percutaneous coronary intervention: 2017 in review. (2018) (6)
Comparison of In-Hospital Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Obese (Body Mass Index ≥ 30 Kg/M2) Patients. (2017) (6)
Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: Results from the CADILLAC trial (2008) (6)
THE USE OF IMPELLA HEART PUMP FOR MANAGEMENT OF WOMEN WITH PERIPARTUM CARDIOGENIC SHOCK (2019) (6)
Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery. (2013) (6)
Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an evidence-based review of recent clinical trial results and report on a roundtable discussion. (2011) (6)
A Statement on Ethics from the HEART Group (2008) (6)
Transcatheter aortic valve replacement: The year in review 2016 (2017) (6)
Clinical End Points of Transcatheter Aortic Valve Implantation Compared With Surgical Aortic Valve Replacement in Patients <65 Years of Age (From the National Inpatient Sample Database). (2018) (6)
Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet Glycoprotein IIb/IIIa Inhibitors: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Consortium (2013) (6)
Short DAPT after DES: P2Y12 monotherapy is in, aspirin is out! (2019) (5)
782-6 Clinical and Angiographic Followup to a Prospective Study of Transluminal Extraction Atherectomy in High Risk Patients with Acute Myocardial Infarction (1995) (5)
Prophylactic intraaortic balloon pumping for acute myocardial infarction does not improve left ventricular function (1996) (5)
Primary percutaneous intervention in octogenarians with acute myocardial infarction: the treatment of choice. (2000) (5)
STEMI telemedicine for 100 million lives (2021) (5)
GENDER DISPARITIES IN ST-ELEVATION MYOCARDIAL INFARCTION CARE AND OUTCOMES IN EMERGING COUNTRIES: A GLOBAL LUMEN ORGANIZATION FOR WOMEN (GLOW) INITIATIVE AND CALL TO ACTION (2016) (5)
Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think Tank (2019) (5)
SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization (2022) (5)
Incidence, Predictors, and In-Hospital Outcomes of Transcatheter Aortic Valve Implantation After Nonelective Admission in Comparison With Elective Admission: From the Nationwide Inpatient Sample Database. (2019) (5)
Is There A Role for Percutaneous Transluminal Coronary Angioplasty without Antecedent Thrombolysis in the Treatment of Acute Myocardial Infarction (1994) (5)
Primary Angioplasty for Acute Myocardial Infarction at Hospitals With No Surgery On-Site: The Prospective Multicenter PAMI-No SOS Registry (1998) (5)
Incidence and predictors of readmissions to non-index hospitals after transcatheter aortic valve replacement and the impact on in-hospital outcomes: From the nationwide readmission database. (2019) (5)
A Paucity of Female Interventional Cardiologists: What Are the Issues and How Can We Increase Recruitment and Retention of Women? (2021) (5)
Evaluation of peripheral vascular diameter and cross-sectional area with a multi-element ultrasonic imaging catheter: Correlation with quantitative angiography (1990) (5)
Coronary perforation: An unreported complication after intracoronary stent implantation (1996) (5)
A statement on ethics from the HEART Group (2009) (5)
Atherothrombotic disease and the role of antiplatelet therapy in women. (2008) (5)
Anticoagulation requirements for coronary interventions and the role of low molecular weight heparins. (1999) (5)
TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-Regression (2021) (5)
Identification of ultra low-risk patients following primary angioplasty for acute myocardial infarction (1996) (5)
Safety of AngioJet thrombectomy in acute ST-segment elevation myocardial infarction: a large, single-center experience. (2006) (5)
Value of transesophageal echocardiography during complex or high-risk coronary interventions in the cardiac catheterization laboratory. (1991) (5)
Hospital outcomes of transcatheter versus surgical aortic valve replacement in female in the United States (2018) (5)
Trends in the Outcomes of High-risk Percutaneous Ventricular Assist Device-assisted Percutaneous Coronary Intervention, 2008-2018. (2021) (4)
Septal Ablation and Hypertrophic Obstructive Cardiomyopathy: 7 Years US Experience. (2016) (4)
Neoatherosclerosis: detection and clinical consequences. (2015) (4)
Percutaneous intervention of unprotected left main coronary artery. (2003) (4)
Medical Misinformation: Vet the Message! (2019) (4)
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction. (2009) (4)
Impella mechanical circulatory support for Takotsubo syndrome with shock: A retrospective multicenter analysis. (2021) (4)
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial). (2003) (4)
Incidence and Predictors of Angiographic Restenosis and Reocclusion After Primary Infarct Stenting - Core lab Analysis From the PAMI Stent Pilot Study (1998) (4)
Infarct vessel patency and bleeding complications after weight-adjusted dosing of a double chain tissue plasminogen activator preparation: Final report (1990) (4)
Can percutaneous coronary intervention be performed safely as an outpatient procedure? (2007) (4)
The Outcomes of Pulmonary Hypertension Patients With Severe Aortic Stenosis Who Underwent Surgical Aortic Valve Replacement or Transcatheter Aortic Valve Implantation. (2019) (4)
Sex Differences in Clinical Characteristics, Management Strategies, and Outcomes of STEMI With COVID-19: NACMI Registry (2022) (4)
Efficacy of angioscopy in determining the effectiveness of intracoronary urokinase and TEC atherectomy thrombus removal from an occluded saphenous vein graft prior to stent implantation. (1995) (4)
The current role of AngioJet rheolytic thrombectomy in acute myocardial infarction. (2010) (4)
Bioresorbable Scaffolds. (2014) (4)
Should we routinely use drug-eluting stents for acute myocardial infarction? Let's wait and see. (2008) (4)
Transcatheter Versus Surgical Aortic Valve Replacement in the United States (From the Nationwide Readmission Database). (2021) (3)
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. (2005) (3)
ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT (2018) (3)
Basic stenting. (2002) (3)
Primary angioplasty. (1995) (3)
Effect of Hospital Volume on Outcomes of Transcatheter Mitral Valve Repair: An Early US Experience. (2015) (3)
Does late reperfusion therapy for myocardial infarction improve left ventricular function? preliminary results of the TAMI-6 randomized, controlled trial (1991) (3)
ST-segment elevation myocardial infarction management: great strides but still room for improvement. (2021) (3)
Debate: Should the elderly receive thrombolytic therapy, or primary angioplasty, for acute myocardial infarction? The case for primary angioplasty (2000) (3)
Relation of time to treatment on relative effects of primary coronary angioplasty vs thrombolytic therapy (2000) (3)
Influence of same‐day admission on outcomes following transcatheter aortic valve replacement (2016) (3)
Magnitude and impact of after hours treatment delay in patients undergoing primary angioplasty for acute myocardial infarction: The CADILLAC Trial (2003) (3)
Mitral valve prolapse postural exercise response reflects a volume disorder (1985) (3)
Primary coronary angioplasty versus thrombolysis for acute myocardial infarction (2003) (3)
Trends of utilization and outcomes after transcatheter and surgical aortic valve replacement on chronic dialysis (2020) (3)
Redo aortic valve intervention after transcatheter aortic valve replacement: Analysis of the nationwide readmission database. (2020) (3)
Variation in utilization of multivessel percutaneous coronary intervention: influence of hospital volume (2015) (3)
Multiple lesion coronary intervention is associated with higher mortality in primary angioplasty for acute myocardial infarction: The stent PAMI trial (2003) (3)
Impaired Culprit Vessel Flow in Acute Coronary Syndromes Ineligible for Thrombolysis (2000) (3)
Bifurcation Stenting: Unnecessary Challenge or a Last Frontier in Intervention (2006) (3)
Panel summary and recommendations on the role of thrombectomy with primary PCI for STEMI. (2010) (3)
Mechanical Circulatory Support in Myocardial Infarction Complicated by Cardiogenic Shock: Impact of Sex and Timing (2022) (3)
Challenges in Cardiovascular Risk Prediction and Stratification in Women (2019) (3)
In‐hospital outcomes of transcatheter versus surgical aortic valve replacement in non‐teaching hospitals (2018) (3)
North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital Mortality (2022) (3)
Predictors of Hospital Cost After Transcatheter Aortic Valve Implantation in the United States: From the Nationwide Inpatient Sample Database. (2019) (3)
Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention (2021) (3)
Sex differences in response to treatments for chronic coronary artery disease. (2009) (3)
CRT-200.92 Gender Disparities in ST-Elevation Myocardial Infarction Care and Outcomes in Emerging Countries: A Global Lumen Organization for Women (GLOW) Initiative and Call to Action (2016) (3)
SCAI consumer survey comparing fear of COVID‐19 versus heart attack or stroke (first publish date: September 4, 2020) (2020) (3)
Does primary stenting in acute myocardial infarction increase mortality (2001) (3)
Percutaneous coronary angioscopy in the assessment of plaque morphology in conjunction with interventional procedures (1991) (3)
Abstracts - ACCIS2002 (angiography & interventional cardiology)Impact of clinical syndrome acuity on the differential response to two glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial (2002) (2)
Rescue angioplasty—the MERLIN trial: Reply (2005) (2)
TCT Annual Meeting (2006) (2)
1002-82 Impact of body mass index on outcomes after primary angioplasty in acute myocardial infarction: The obesity paradox (2004) (2)
Differences in risk factors and resource utilization for women undergoing percutaneous coronary intervention and lower extremity peripheral vascular intervention (2020) (2)
Management of Complex Cardiovascular Problems (2001) (2)
Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents (2022) (2)
Use of a compressive leverage apparatus versus manual pressure in achieving hemostasis after invasive procedures (1993) (2)
Practical Handbook of Advanced Interventional Cardiology: Fourth Edition (2012) (2)
Streptokinase angioplasty myocardial infarction trial: Early and late results (1991) (2)
Hospital variation of 30-day readmission rate following transcatheter aortic valve implantation (2021) (2)
Response to Letter Regarding Article "Impact of Annual Operator and Institutional Volume on Percutaneous Coronary Intervention Outcomes: A 5-Year United States Experience (2005-2009)". (2015) (2)
Should every patient undergo cardiac catheterization after myocardial infarction? (1994) (2)
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: The cadillac trial (2003) (2)
ULTRASOUND ACCELERATED THROMBOLYSIS IN PATIENTS WITH ACUTE PULMONARY EMBOLISM: A SYSTEMATIC REVIEW AND PROPORTION META-ANALYSIS (2016) (2)
Medical misinformation: vet the message! (2019) (2)
Orbital atherectomy for the treatment of small (2.5mm) severely calcified coronary lesions: ORBIT II sub-analysis. (2018) (2)
Transcatheter pulmonary valve implantation: a cross-sectional US experience. (2015) (2)
Primary stenting optimizes the outcome of women with acute myocardial infarction: results from the CADILLAC trial (2002) (2)
Point - Counterpoint: The wide use of IIb/IIIa inhibitors in interventional cardiology - is it justified? (1999) (2)
Age stratified sex‐related differences in incidence, management, and outcomes of cardiogenic shock (2021) (2)
Inter-assay variability in the degree of platelet inhibition following GPIIb/IIIa receptor blockade in patients undergoing coronary intervention: a comparison of three different point-of-care assays (2002) (2)
Abciximab use during percutaneous intervention in patients with acute myocardial infarction improves early and late clinical outcomes: Final results of the CADILLAC trial (2001) (2)
Impact of hospital and sociodemographic factors on utilization of drug-eluting stents in 2011–2012 Medicare cohort (2017) (2)
Toxoplasma meningoencephalitis with hypoglycorrhachia. (1981) (2)
Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011) (2016) (2)
Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions 2020 think tank (2020) (2)
Risk of Ischemic Stroke in Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Prior Stroke. (2021) (2)
Contemporary management of acute MI (2003) (2)
TCT-121 Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the cVAD Registry. (2016) (2)
Guides and wires. (2001) (2)
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction. (2004) (2)
Antithrombotic therapy in the catheterization laboratory : interim analysis of the NICE trials (2000) (2)
Acute coronary syndromes: Acute MI in women—the fountain of youth has run dry (2015) (2)
Management of Complex Cardiovascular Problems: Nguyen/Management (2016) (2)
Effect of stent implantation and glycoprotein IIb/IIIa receptor blockade on target vessel revascularization in diabetics after primary PCI in acute myocardial infarction: the CADILLAC trial (2002) (2)
Medical Misinformation: Vet the Message! (2019) (2)
Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial (2002) (2)
2: Early Objective Identification of Chest Pain Patients at Very Low Risk of 30-Day Adverse Outcomes (2009) (2)
The value of exercise echocardiography in detecting multivessel coronary disease following successful reperfusion of acute myocardial infarction (1990) (2)
“How can SCAI and industry partners increase adherence and educate interventionalists on optimal medical therapy?” (2018) (2)
Comparison of an intravenous bolus of enoxaparin versus unfractionated heparin in elective coronary angioplasty (1999) (2)
Women and Calcium: A Love-Hate Relationship at the Center of the Heart. (2016) (2)
Ischemia-driven target vessel revascularization after-primary percutaneous coronary intervention: patients at risk and their outcomes. (2005) (2)
The Effect of Interventricular Asynchrony (2005) (2)
Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions (SCAI) 2021 think tank (2021) (2)
Transcatheter cardiovascular therapeutics annual meeting. (2006) (1)
A Statement on Ethics from the HEART Group (2008) (1)
Predictors of treatment delay in patients with acute myocardial infarction undergoing primary angioplasty: An analysis from the CADILLAC trial (2003) (1)
Elevated C-reactive protein in diabetics with acute coronary syndrome: culprit or innocent bystander? (2002) (1)
1000–37 The “Long Long” Balloon Pilot: Dilatation of Class C Coronary Lesions Using Slow, Oscillating, Prolonged Inflation of 40 mm Balloons (1995) (1)
The hemorrhage of information to reduce bleeding complications after percutaneous coronary intervention. (2013) (1)
ACCF Complementary Medicine Expert Consensus Document — Online Appendices Integrating Complementary Medicine Into Cardiovascular Medicine (2005) (1)
Abstract 19960: Variation of Utilization of Intravascular Ultrasound and Fractional Flow Reserve in the United States: Influence of Hospital Volume (2014) (1)
Importance of mitral regurgitation inpatients undergoing percutaneous coronaryintervention for acute myocardial infarction (2016) (1)
HOSPITALIZATION BURDEN OF DIASTOLIC HEART FAILURE IN THE UNITED STATES: 2007-2012 (2017) (1)
Impella Versus Intra-Aortic Balloon Pump for High-Risk PCI: A Propensity-Adjusted Large-Scale Claims Dataset Analysis. (2022) (1)
Representation of Women in Internal Medicine Specialties in North America, the United Kingdom, and Australasia: Cardiology's Outlier Status and the Importance of Diversity. (2022) (1)
Mechanical Circulatory Support in Patients With COVID-19 Presenting With Myocardial Infarction (2022) (1)
Abstract 17304: Comparison of Inpatient Outcomes Among Patients With and Without Systemic Vasculitis Admitted With Acute Myocardial Infarction in the United States: The National (Nationwide) Inpatient Sample 2000-2012 (2017) (1)
778-4 Is Primary Angioplasty Less Effective in Patients with Acute Myocardial Infarction Presenting in the Early Morning Hours? (1995) (1)
Abstract 17531: Two-Year Clinical Results Comparing Abciximab vs. Eptifibatide in Combination With 600mg vs. 300mg Clopidogrel Loading Dose in Patients With ST-Elevation Myocardial Infarction: Results from the HORIZONS-AMI Trial (2010) (1)
Sex-Specific Outcomes in Cardiovascular Device Evaluations. (2020) (1)
Role of prolonged intravenous heparin in unstable angina patients prior to coronary angioplasty. (2001) (1)
MANUAL ASPIRATION THROMBECTOMY (MAT) DOES NOT IMPACT SHORT OR LONG TERM SURVIVAL IN PRIMARY PCI: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR COLLABORATIVE (BMC2) (2014) (1)
Optimization of platelet therapy. (2000) (1)
Timing and risk factors for enzymatic myocardial infarctions in patients undergoing percutaneous intervention: Insights from TARGET (2003) (1)
Spontaneous coronary artery dissection. (2008) (1)
Characterization of myocardial oncogenes after infarction and reperfusion (1991) (1)
Choice of DES: A US Clinician's Perspective (2009) (1)
Editorial: The Conundrum of Calcified Coronaries. (2017) (1)
Fibrinolytic and mechanical intervention trials in ST elevation acute myocardial infarction. (2002) (1)
Commentary on late breaking trials in interventional cardiology at ESC, VIVA, TCT, AHA (Fall 2012), and ACC 2013 (2014) (1)
SCAI digital education bridging the gap (October 31, 2020) (2020) (1)
Interventional Cardiology AbstractsOutcomes of optimal or “stent-like” balloon angioplasty in acute myocardial infarction: the CADILLAC trial (2004) (1)
Early Discharge After ST-Segment Elevation Myocardial Infarction: The Days Are Getting Shorter! (2021) (1)
Medical misinformation: Vet the message! (2019) (1)
Responses to the editor RE: McCullough PA, Roberts WC. Peter Andrew McCullough, MD, MPH: An interview with the editor. Am J Cardiol 2014;114:1772-1785. (2015) (1)
Primary PTCA results in similar in-hospital outcomes in females and males presenting with acute MI (1996) (1)
Unplanned Thirty-Day Readmission After Alcohol Septal Ablation for Hypertrophic Cardiomyopathy (From the Nationwide Readmission Database). (2020) (1)
Abstract 13933: A Comparative Analysis of 30-day Readmission Rates, Etiologies and Resource Utilization Following Transcatheter and Surgical Aortic Valve Replacement From the Nationwide Readmission Database (2016) (1)
The DISCO study—Does Interventionalists' Sex impact Coronary Outcomes? (2021) (1)
Management of multivessel coronary disease: let us not shortchange drug-eluting stents. (2008) (1)
TCT-63 North American COVID-19 Myocardial Infarction (NACMI) Risk Score for Prediction of In-Hospital Mortality (2021) (1)
Editorial: a new beginning and ending? (2011) (1)
The Primary Angioplasty in Myocardial Infarction Studies: An Overview (1998) (1)
Chapter 19 – Percutaneous Coronary Intervention (2018) (1)
Frequency, determinants, and clinical implications of angiographically-visible intracoronary thrombus following primary angioplasty for acute myocardial infarction (2002) (1)
Baseline features and clinical results in patients excluded from randomization from a large international trial of reperfusion strategies in acute myocardial infarction: The CADILLAC Registry (2003) (1)
Chapter 20 – Percutaneous Coronary Intervention (2010) (1)
Intervention Without On-Site Surgical Backup SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary (2014) (1)
Use of low-molecular-weight heparin in percutaneous intervention. (2000) (1)
919-14 What is the Ideal Burr Size for Rotablator Atherectomy? (1995) (1)
SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup. (2023) (1)
Multivessel angioplasty versus bypass surgery. A case for PTCA. (1995) (1)
Vaccination Serology Status and Cardiovascular Mortality: Insight from NHANES III and Continuous NHANES (2015) (1)
Medical Misinformation. (2019) (1)
Left Main Stem Percutaneous Coronary Intervention: Does On-Site Surgical Cover Make a Difference? (2022) (1)
Treatment of acute myocardial infarction [1] (1993) (1)
In-hospital and Late Outcomes Following Primary Stenting in Acute Myocardial Infarction-Comparison With Primary PTCA (1998) (1)
Mechanical circulatory device utilization in cardiac arrest: Racial and gender disparities and impact on mortality. (2022) (1)
TCT CONNECT-70 Nationwide Trends of Resource Utilization and Outcomes of TAVR Versus SAVR in Patients on Chronic Dialysis (2020) (0)
Whit ombining Antiplatelet nd Anticoagulant Therapies (0)
Baseline Morphology of 158 Saphenous Vein Bypass Graft Leslons Treated by Transluminal Extraction Coronary Atherectomy (2005) (0)
Abstract 20050: Impact of Median Household Income and Hospital Variation in the Utilization of Do-not-resuscitate Order in Cardiac Arrest: A National Perspective (2014) (0)
Are Residual Stenoses After Excimer Laser An ioplasty and Coronary Atherecto y e to Inefficient or a Devices ? Comparison it Balloon (2016) (0)
IAGS 2022 Summary Document: 16th Biennial Meeting of the International Andreas Gruentzig Society held January 31-February 3, 2022 in Punta Cana, Dominican Republic. (2022) (0)
Dealing with Adverse Events: What's Preventable and What's Not (2019) (0)
1043-64 Adverse outcomes in women undergoing percutaneous coronary intervention (2004) (0)
Coronary Revascularization in the Era of Transcatheter Aortic Valve Replacement: Treat the Patient, Manage the Disease (2021) (0)
TCT-570 In-Hospital Outcomes of Transcatheter Aortic Valve Replacement After Non-Elective Admission in Comparison with Elective Admission (2018) (0)
Reperfusion therapy improves infarct zone wall motion in inferior as well as anterior wall MI (1991) (0)
Bradycardia, hypotension, and chronotropic incompetence are common with acute proximal versus distal RCA occlusion (2002) (0)
COMPARISON OF OUTCOMES OF BILATERAL INTERNAL MAMMARY ARTERY BYPASS AND SINGLE INTERNAL MAMMARY ARTERY BYPASS: ANALYSIS OF 149,619 PROCEDURES (2016) (0)
TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT IN DIABETES MELLITUS: FROM THE NATIONWIDE INPATIENT SAMPLE (2017) (0)
NATIONWIDE HOSPITAL OUTCOMES OF TIMED PERCUTANEOUS CORONARY INTERVENTION IN OCTOGENARIANS (2018) (0)
Cost analysis of different management strategies for myocardial infarction (1996) (0)
New equipment and techniques enhance capabilities of trans-radial PCI. (2011) (0)
179 - Despite Higher Morbity and Mortality Risk Women Had Similar Outcomes and Improvement in Heart Failure as Men in Complex PCI with Impella Hemodynamic Support (2017) (0)
DISCHARGE MEDICATION USE IN PATIENTS WHO EXPERIENCE BLEEDING COMPLICATIONS AFTER PRIMARY PCI: ANALYSIS FROM HORIZONS-AMI (2011) (0)
Women Are Complex Creatures. (2016) (0)
BURDEN OF ARRHYTHMIAS IN PERIPARTUM CARDIOMYOPATHY: ANALYSIS OF 9,840 HOSPITALIZATIONS (2016) (0)
Interventional Cardiology: The Essentials for the Boards: Questions and Answers, Clinical Cases, and Pearls (2000) (0)
The importance of your membership and involvement (2020) (0)
SCAI COVID 19 Updated Consumer Survey Shows Continued Concern of Patients, Especially among Underserved Populations (2021) (0)
P3589Outcome of women compared with men in patients undergoing complex percutaneous coronary intervention with hemodynamic support (2018) (0)
TCT-335 Association Between Utilization of Mechanical Circulatory Devices in Patients With Cardiac Arrest and In-Hospital Mortality (2021) (0)
Where Did it Go? Equipment Loss and/or Entrapment (2019) (0)
Comprar Management Of Complex Cardiovascular Problems 4th Ed. | Thach Nguyen | 9781118965030 | Wiley (2016) (0)
Proceedings from the Society for Cardiovascular Angiography and Interventions 2022 Think Tank: Coronary Session on Calcium Management (2022) (0)
The year in interventional cardiology. (2009) (0)
Percutaneous coronary intervention versus coronary artery bypass grafting: clinical outcomes in multivessel coronary artery disease. (2002) (0)
ED to catheterization laboratory: a roundtable integrating trials with practice. (2011) (0)
Contemporary management of carotid artery stenosis: no resting places, no plateaus. (2006) (0)
Presidents Message_Amplifying DEI Efforts at SCAI DRAFT. (2021) (0)
LB-3 | Sex Differences in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19 (2022) (0)
811-4 Coronary Doppler Flow Velocity and PET Myocardial Blood Flow are Highly Correlated and Predict Post-Infarction Perfusion In Patients with TIMI 3 Flow (1995) (0)
The role of enoxaparin in interventional management of patients with acute coronary syndromes. (2003) (0)
1043-44 Identifying patients at risk for ischemia-driven target vessel revascularization after primary percutaneous coronary intervention: Lessons from the primary angioplasty in myocardial infarction (PAMI) trials (2004) (0)
Why do smokers have a better prognosis with acute myocardial infarction? Insights from the PAMI-2 trial (1996) (0)
Contrast-induced Nephropathy: Acute Kidney Injury (2010) (0)
IMPACT OF HOSPITAL AND SOCIO-DEMOGRAPHIC FACTORS ON DRUG-ELUTING STENT USE IN THE 2011-2012 MEDICARE COHORT: CHOICES, CHANCES, CHANGES (2015) (0)
Current references: Directed angioplasty in acute myocardial infarction (2005) (0)
Does prior angina predict outcomes following acute myocardial infarction? Testing the relevance of ischemic pre-conditioning in the era of primary angioplasty (2002) (0)
CRT-700.34 Short-Term Outcomes Among Aortic Valve Stenosis Patients Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention (2023) (0)
INCIDENCE, PREDICTORS, AND IMPACT OF READMISSIONS TO NON-INDEX HOSPITALS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT ON IN-HOSPITAL OUTCOMES: FROM THE NATIONWIDE READMISSION DATABASE (2019) (0)
Integrating Coronary Stents and Glycoprotein IIb/IIIa Inhibitors into a Mechanical Reperfusion Strategy: The CADILLAC and ADMIRAL Trials (2002) (0)
ROTATIONAL ATHERECTOMY VERSUS STANDARD PCI IN PATIENTS WITH CALCIFIED CORONARY LESIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS (2018) (0)
SEX DIFFERENCES IN IMPELLA SUPPORTED HIGH RISK PERCUTANEOUS CORONARY INTERVENTION OUTCOMES (2023) (0)
ECONOMIC IMPLICATIONS OF LATE DISCHARGE AFTER TRANSCATHETER AORTIC CATHETER IMPLANTATION (2017) (0)
Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013 (2015) (0)
Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease (2022) (0)
Adverse Outcomes Prior to Hospital Discharge After Primary Stenting for Acute Myocardial Infarction Are Often Predictable, and Related to Correctable Technical Factors (1998) (0)
IMPACT OF HOSPITAL LEVEL VARIANCE IN RISK-STANDARDIZED READMISSION RATES AFTER TAVR (2021) (0)
Does optimal or stent-like PTCA provide equivalent outcomes compared to primary stenting in acute myocardial infarction? Early and late results from the CADILLAC trial (2002) (0)
Poor one year prognosis in acute myocardial infarction patients with saphenous vein grafts as the infarct related vessel treated by primary balloon angioplasty (2002) (0)
Medical Misinformation. (2019) (0)
rocedural Success Versus Clinical Risk Status n Determining Discharge of Patients After rimary Angioplasty for Acute Myocardial Infarction (2016) (0)
TCT CONNECT-181 A Propensity Matched Analysis of Impella Use From a Large-Scale Claims Data: Influence of Analytic Methodology on Clinical Outcomes (2020) (0)
A-1 | Acute Stent Thrombosis and In-stent Restenosis in Cancer Patients Treated with Bare Metal Stents versus Drug Eluting Stents (2022) (0)
TCT CONNECT-483 Stroke Risk Following TAVR Versus SAVR in Patients With Prior Stroke: A Nationwide Perspective (2020) (0)
Abstract 1272: Vascular Endothelium Growth Factor-165 Gene Therapy Promotes Cardiomyogenesis in Reperfused Myocardial Infarction (2006) (0)
IN-HOSPITAL OUTCOMES AFTER MITRACLIP IMPLANTATION: NATIONWIDE INPATIENT SAMPLE, 2010-2014 (2018) (0)
Does abciximab and stenting improve outcomes in elderly patients undergoing primary PCI for acute myocardial infarction: data from the CADILLAC trial (2002) (0)
Peripheral vascular interventional advances in 2017 (2018) (0)
Inaugural President's Address (2020) (0)
Valvular disease-Aortic : Balloon Aortic Valvuloplasty (2014) (0)
Cine film replacement: Application of real-time digital cassette tape to coronary arteriography (1990) (0)
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases. (2007) (0)
Does the method of administering fluids matter for contrast‐induced nephropathy? REMEDIAL III compares LVEDP versus urine flow‐guided hydration (2020) (0)
Calcified coronary nodule: Tip of the iceberg on a road full of thorns (2023) (0)
MYOCARDIAL INFARCTION Analysis of the Relative Costs and Effectiveness of Primary Angioplasty Versus Tissue-Type Plasminogen Activator: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial (2016) (0)
TCT-533 Predictors of High Hospital Cost After Transcatheter Aortic Valve Replacement in the United States: Analysis of Nationwide Inpatient Sample Database (2018) (0)
Shock Protocols May Decrease Racial, Ethnic, and Sex Disparities in Acute Myocardial Infarction and Cardiogenic Shock (2022) (0)
The salutary effect of prior beta blocker therapy on clinical outcomes following primary angioplasty for acute myocardial infarction: a pooled analysis from the Primary Angioplasty in Myocardial Infarction (PAMI:1), PAMI:2, and stent:PAMI trials (2002) (0)
801-2 Predictors of survival after primary percutaneous coronary intervention: The impact of myocardial perfusion grade in female patients (2004) (0)
Temporal trends of one-year reinfarction and mortality rates following primary angioplasty in high-risk acute myocardial infarction patients (2003) (0)
DOES MINIMALLY-INVASIVE BYPASS SURGERY AFFORD A LONG-TERM SURVIVAL ADVANTAGE COMPARED WITH DRUG-ELUTING STENT FOR ISOLATED COMPLEX DISEASE OF THE LEFT ANTERIOR DESCENDING CORONARY ARTERY? (2018) (0)
Long-term outcome in patients with acute myocardial infarction undergoing primary percutaneous intervention: a pooled analysis of the primary angioplasty in myocardial infarction trials (2002) (0)
COMPLEX HIGH-RISK PERCUTANEOUS CORONARY INTERVENTION TYPES, TRENDS, AND OUTCOMES IN NON-SURGICAL CENTRES (2023) (0)
Abstracts of the Scientific Meeting of the Netherlands Society of Cardiology (NVVC). (2006) (0)
PREDICTORS OF EARLY DISCHARGE HOME AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION (2017) (0)
768-4 What is Unique About the Infarct Related Artery and How Do These Features Influence Success During Direct PTCA for AMI (1995) (0)
Outcome after acute myocardial infarction in young patients: analysis of the PAMI database (2002) (0)
Do interventionalists undersize devices during acute infarct intervention? Comparison of angiographic and intravascular ultrasound measures from the PAMI stent randomized trial (1999) (0)
Does stenting benefit patients with left anterior descending infarction? Results from the CADILLAC trial (2002) (0)
Medical misinformation: vet the message! (2019) (0)
Revascularization Strategies in Women with Stable Cardiovascular Disease: What do the Trials Reveal? (2012) (0)
Volume-outcome relationship for peripheral endovascular interventions: a review of existing literature (2016) (0)
IMPACT OF ASPIRIN DOSE ON LONG TERM CLINICAL OUTCOMES AFTER STENTING FOR ACUTE MYOCARDIAL INFARCTION: 3-YEAR FOLLOW-UP DATA FROM THE HORIZONS-AMI TRIAL (2011) (0)
Percutaneous Coronary Intervention for Acute Myocardial Infarction Prognostic Implications of Creatine Kinase Elevation After Primary (2011) (0)
TCT-70 Clinical Predictors of Patients Requiring Prolonged Mechanical Circulatory Support After High-Risk PCI (2022) (0)
AORTIC DEBRIS AND CORONARY GUIDING CATHETERS. AUTHORS' REPLY (1999) (0)
Abstract 1762: Relationship Between Leucocyte Count, Myonecrosis, Myocardial Perfusion and Outcomes Following Primary Angioplasty (2006) (0)
A New Era of Drug-Eluting Stents (2009) (0)
Outcomes in patients requiring bail-out abciximab during primary intervention in acute myocardial infarction: Analysis from the CADILLAC trial (2003) (0)
TRANSCATHETER VERSUS SURGICAL VALVE REPLACEMENT IN NON-ELDERLY (AGE LESS THAN 65): IN-HOSPITAL OUTCOMES FROM THE NATIONAL INPATIENT SAMPLE (2018) (0)
MORTALITY AND MORBIDITY REDUCTION BY PRIMARY PERCUTANEOUS CORONARY INTERVENTION IS CONSISTENT ACROSS SPECTRUM OF AGE (2010) (0)
Women leaders: transforming the culture in cardiology (2022) (0)
Percutaneous coronary intervention for acute myocardial infarction: current strategy in the lab. (2007) (0)
PET myocardial blood flow and coronary doppler flow velocity are highly correlated and predict post-infarction perfusion in patients with TIMI 3 flow (1995) (0)
Marked mortality risk of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction (2003) (0)
ACCF / AHA EXPERT CONSENSUS DOCUMENT ACCF / AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring By Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain (2009) (0)
Abstract 920: Is Balloon Angioplasty without Stent Placement Adequate for Patients in Whom Early Coronary Artery Bypass Surgery Is Planned after Primary Percutaneous Coronary Intervention? (2008) (0)
1081-59 Target vessel revascularization during the first month after bare metal coronary stenting: Clinical indications and angiographic findings (2004) (0)
Medical Misinformation. (2019) (0)
801-3 Anemia worsens prognosis after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial (2004) (0)
Clinical Study Early Real-World Experience with CoreValve Evolut PRO and R Systems for Transcatheter Aortic Valve Replacement (2019) (0)
Outcome of Cardiac Tamponade Complicating Percutaneous Coronary Intervention (2002) (0)
Left ventricular remodeling is the most common cause of systolic dysfunction after acute myocardial infarction: Findings from the stent-PAMI study (2003) (0)
PERCUTANEOUS CORONARY INTERVENTION RATES IN NSTEMI CASES AND IN-HOSPITAL OUTCOMES IN THE UNITED STATES DURING YEARS 2002-2014 (2018) (0)
1070-104 Age-related complications and outcomes after primary percutaneous coronary interventions (2004) (0)
Effect of Race on Clinical Outcomes Following Hemodynamically Supported High-Risk Percutaneous Coronary Intervention (2023) (0)
Medical misinformation: vet the message! (2019) (0)
RACIAL DIFFERENCES IN CLINICAL FEATURES AND OUTCOMES OF PATIENTS UNDERGOING HIGH RISK PCI WITH HEMODYNAMIC SUPPORT IN A CONTEMPORARY COHORT (2021) (0)
TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US (2014) (0)
Diabetics: To stent, or not to stent… Is that the question, or is it “which stent?” (2020) (0)
mpact of Diabetes Mellitus on Myocardial erfusion After Primary Angioplasty n Patients With Acute Myocardial Infarction (2016) (0)
TCT-368 Racial and Gender Disparities in the Utilization of Mechanical Circulatory Devices in Patients With Cardiac Arrest (2021) (0)
Gender is an independent predictor of both in-hospital and one-year outcomes following primary intervention for acute myocardial infarction (2002) (0)
Left ventricular aneurysm: What is the role of surgical or percutaneous interventions? (2021) (0)
CRT-700.05 Impella Utilization in High-Risk Percutaneous Coronary Intervention Mitigates the Risks of Procedural and Clinical Adverse Events Independent of Left Ventricular Ejection Fraction: The Protect III Study (2023) (0)
869-1 Relationship between time to reperfusion, ST-segment resolution, myocardial blush scores and mortality with primary percutaneous coronary intervention for acute myocardial infarction: Results from the CADILLAC trial (2004) (0)
Differences in outcome after angioplasty for acute myocardial infarction: The left anterior descending artery vs. the right coronary artery (1996) (0)
Medical Misinformation. (2019) (0)
Abstract 491: Effect of Gender on Management of Suspected Coronary Artery Disease After Coronary CT Angiography (2009) (0)
Con: The Trials are Inadequate in Women—Devices Should Be Used Earlier and More Often (2019) (0)
PCI Complications: Dissections, Rupture, Embolization, and Closure (2013) (0)
Absence of ST elevation during myocardial infarction identifies a patient population with advanced disease and increased need for revascularization (1991) (0)
RECENT TRENDS IN HOSPITALIZATION FOR CORONARY ARTERY DISSECTION (NATIONWIDE INPATIENT SAMPLE, 2007-2012) (2016) (0)
The cloak of calcium: Coronary angiography is not to be trusted (2021) (0)
PATENT FORAMEN OVALE CLOSURE VERSUS MEDICAL THERAPY TO PREVENT RECURRENT STROKE: A META-ANALYSIS AND TRIAL SEQUENTIAL ANALYSIS (2018) (0)
1018-48 Comparative Results of Extraction Atherectomy (TEC) in Vein Graft Lesions with and without Thrombus (1995) (0)
Should we use invasive fractional flow reserve (FFR), imaging, or both to determine the significance of a “borderline” lesion? (2022) (0)
Errata (1918) (0)
Abstract 13942: Do Geographic Trends in Aspirin Discharge Dose Alter Outcomes After STEMI and Primary PCI: Results From the HORIZONS-AMI Trial (2011) (0)
The year in interventional cardiology. (2010) (0)
1022-107 Outcome of Different Reperfusion Strategies in Thrombolytic “Eligible” versus “Ineligible” Patients with Acute Myocardial Infarction (1995) (0)
SCAI is working with National Medical and Governmental Leaders (September 11, 2020) (2020) (0)
Prognosis after AMI-related cardiogenic shock: myocardial blush score is one piece of the puzzle. (2021) (0)
NATIONWIDE TRENDS AND OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTIONS FOLLOWING DIAGNOSTIC ANGIOGRAPHY PERFORMED BY NON-INTERVENTIONAL CARDIOLOGIST VERSUS INTERVENTIONALISTS: INSIGHTS FROM THE CATHPCI REGISTRY (2021) (0)
Usefulness of electron-beam computed tomography. Discussion (2002) (0)
Integrating Coronary Stents and Glycoprotein IIb/IIIa Inhibitors into a Mechanical Reperfusion Strategy (2002) (0)
Balloon angioplasty. (2001) (0)
Arnon Blum Role of Lymphocytes in Heart Disease (1998) (0)
CONTEMPORARY OUTCOMES OF EMERGENT UNPROTECTED LEFT MAIN ARTERY STENTING: INSIGHTS FROM BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR COLLABORATIVE (BMC2) (2016) (0)
Editorial: another reason for women to avoid estrogen? (2014) (0)
Transradial for complex coronary interventions: breaking the glass ceiling in coronary interventions. (2014) (0)
Another nail in the coffin for the use of risk‐adjusted mortality after percutaneous coronary intervention as a quality indicator (2020) (0)
Relationship between time to treatment, electrocardiographic ST-segment resolution, and outcomes with primary percutaneous coronary intervention for acute myocardial infarction: Results from the CADILLAC trial (2003) (0)
815-6 Prognostic effect of left bundle brunch block on presenting electrocardiogram in patients with acute myocardial infarction treated with primary angioplasty in the primary angioplasty in myocardial infarction trials (2004) (0)
Sex Disparities in Interventional and Structural Heart Procedures (2022) (0)
TCT-146 Left Main Stem Percutaneous Coronary Intervention: Does Onsite Surgical Cover Make a Difference? (2022) (0)
CRT-100.38 Shock Protocols May Decrease Racial, Ethnic, and Sex Disparities in Acute Myocardial Infarction and Cardiogenic Shock (2022) (0)
Clinical and angiographic predictors of abnormal doppler-derived flow in the infarct related artery after primary angioplasty for acute myocardial infarction (2002) (0)
Beta-Blockers in Myocardial Infarction ustained Ventricular Tachycardia or ibrillation in the Cardiac Catheterization aboratory Among Patients Receiving rimary Percutaneous Coronary Intervention ncidence , Predictors , and Outcomes (2016) (0)
Overview of the i2 (Innovation in Intervention) Summit 2006 (2006) (0)
Two-year outcomes following percutaneous intervention: Beaumont Angiotensin converting enzyme Genotype and Endpoints Trial (the BAGET trial) (2002) (0)
TCT-99 Short- and Long-Term Outcomes of Patients With Chronic Kidney Disease Undergoing Protected High-Risk Percutaneous Coronary Intervention (2022) (0)
TCT-604 Outcome of High Risk Percutaneous Coronary Intervention: Gender-Based Analysis (2018) (0)
Late breaking trials of 2014 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA (2015) (0)
869-2 Impact of intravenous beta-blockade during primary percutaneous intervention on convalescent left ventricular function (2004) (0)
Comprar Practical Handbook of Advanced Interventional Cardiology | Shigeru Saito | 9781405169554 | Blackwell Publishing (2007) (0)
1062-42 Adverse events in patients with normal renal function are increased with modest increases in creatinine clearance after percutaneous coronary intervention (2004) (0)
STEMI in the cancer patient: Do not withhold primary PCI! (2020) (0)
Medical Misinformation. (2019) (0)
Letter regarding article by Nallamothu et al, "Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United states". (2005) (0)
President's Message: Amplifying SCAI's DEI Efforts (2021) (0)
Rarity of circumflex culprits in ST-elevation MI is due to relative ECG silence (2002) (0)
A Statement on Ethics from the HEART Group (2010) (0)
Treatment of Acute Infarction With PCI Outcomes of Optimal or “ Stent-Like ” Balloon Angioplasty in Acute Myocardial Infarction : The CADILLAC Trial (2016) (0)
2021. The year in review. Structural heart interventions (2022) (0)
The year in interventional cardiology. (2007) (0)
Editorial: Spontaneous coronary artery dissection: A new dilemma, or just new recognition of an old problem? (2018) (0)
Vascular access. (2020) (0)
(cadillac) trial abciximab and device investigation to lower late angioplasty complications primary percutaneous coronary intervention: Analysis from the controlled Impact of anemia in patients with acute myocardial infarction undergoing (2011) (0)
A prospective study of large vs. small burrs: Intravascular ultrasound findings in the coronary angioplasty and rotablator atherectomy trial (CARAT) (1996) (0)
Coronary Revascularization Before Transcatheter Aortic Valve Replacement: It Is Safe, But Is It Necessary? (2020) (0)
Between a rock and a hard place: Orbital atherectomy for under‐expanded stents (2021) (0)
Primary Angioplasty in Health Care Delivery: The North American Model (2010) (0)
Prognostic value of the absolute degree of ST-segment elevation of the ECG at baseline and after primary angioplasty: Analysis from the CADILLAC trial (2003) (0)
NON-STEMI COMPLICATED BY CARDIOGENIC SHOCK REQUIRING PERCUTANEOUS MECHANICAL SUPPORT HAVE WORSE OUTCOMES (2018) (0)
Medical Misinformation - Vet the Message! (2019) (0)
THE IMPACT OF WORSENING RENAL DYSFUNCTION ON THE COMPARATIVE EFFICACY OF BIVALIRUDIN AND PLATELET GLYCOPROTEIN IIBIIIA INHIBITORS: INSIGHTS FROM BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM (BMC2) (2013) (0)
Transcatheter aortic valve replacement: The year in review 2016. (2017) (0)
Primary Percutaneous Coronary Intervention: The Deception of Delay⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. (2013) (0)
Primary angioplasty leads to a low incidence of adverse outcomes in patients with the substrate for right ventricular infarction (1996) (0)
Invasive imaging of myocardial infarction patients: Is less or more better? (2020) (0)
TCT-545 Angiographic Features, Lesion, and Procedural Characteristics in Patients With Chronic Kidney Disease Undergoing Protected High-Risk Percutaneous Coronary Intervention (2022) (0)
It's not shocking that the SCAI shock classification works (2020) (0)
720-2 Predictors of Acute Complications After Percutaneous Coronary Revascularization with New Devices (1995) (0)
TCT-243 Are Percutaneous Patent Foramen Ovale Closure Devices effective? A Comprehensive Meta-Analysis Assessing their Long Term Outcomes (2018) (0)
Acute myocardial infarction related cardiogenic shock: How important is vascular access site? (2021) (0)
Directional coronary atherectomy revisited (2022) (0)
Disparate clinical outcomes of diabetic and nondiabetic patients undergoing primary angioplasty for acute myocardial infarction: is diabetes mellitus an independent predictor of poor outcome? (2002) (0)
Medical Misinformation. (2019) (0)
Circadian fluctuations in thrombogenicity in patients undergoing primary angioplasty for acute myocardial infarction (2003) (0)
TCT-237 Revascularization Options for Women With Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials (2019) (0)
Comprar Management of Complex Cardiovascular Problems | Thach Nguyen | 9781405140317 | Blackwell Publishing (2007) (0)
Is operator interpretation or core lab analysis more accurate in predicting in-hospital adverse events after primary PTCA? (1998) (0)
Turndown for coronary artery bypass surgery: Never say never to revascularization (2022) (0)
Meta-Analysis Comparing Patent Foramen Ovale Closure Versus Medical Therapy to Prevent Recurrent Stroke Short title : PFO closure in cryptogenic stroke (2017) (0)
Adequate preparation of complex left main lesions prior to stenting appears to level the playing field (2021) (0)
Current controversies in patient selection for thrombolytic therapy. (1990) (0)
Stent Mania: Proving Efficacy and Improving Safety (1998) (0)
Acute MI in the elderly: choosing the best revascularization method. Risks and benefits of thrombolysis, angioplasty, and bypass surgery. (1993) (0)
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease (2022) (0)
1061-100 Predictors of reinfarction after ST elevation myocardial infarction and glycoprotein receptor blockade: Analysis from the CADILLAC trial (2004) (0)
Safety profile of glycoprotein IIb/IIIa inhibitors in octogenerians (2002) (0)
TCT CONNECT-184 Impact of Sex and Timing of Impella Support in Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock (2020) (0)
TCT-403 Trends in the Use of Mechanical Circulatory Devices in Cardiac Arrest, 2015 to 2018 (2021) (0)
Covered stents: Initially life‐saving but long‐term consequences persist (2021) (0)
IN-HOSPITAL OUTCOMES AFTER MITRACLIP IMPLANTATION IN THE UNITED STATES: 2010-2012 (2017) (0)
My vision for the journal of interventional cardiology. (2005) (0)
ST-Segment Elevation Myocardial Infarction: Sex Differences in Incidence, Etiology, Treatment, and Outcomes (2022) (0)
TCT-118 Propensity-Adjusted Population-Based Analysis of Impella in Patients Undergoing High-Risk PCI From a Large-Scale Claims Dataset (2021) (0)
Clinical implications of myocardial perfusion status assessed by myocardial blush after primary angioplasty in acute myocardial infarction: Analysis from the CADILLAC trial (2003) (0)
Transradial Coronary Angiogram in a Sitting Position. (2017) (0)
Reassessing Patients Over Time : How To Follow Patients on Treatment (2009) (0)
Can percutaneous coronary interventions be performed safely in leukemia patients? (2020) (0)
The DELTA MI ( Direct Inhibition of Protein Kinase Enyzme to Limit Total Infarct Size in Acute Myocardial nfarction ) trial (2008) (0)
Abstract 14818: Impact of Hospital and Socio-demographic Factors on Utilization of Drug-eluting Stents in Medicare Patients: Bringing Clarity to Disparity (2014) (0)
Medical Misinformation: Vet the Message! (2019) (0)
Safety of an early discharge strategy following primary intervention with adjunctive glycoprotein IIb/IIIa inhibition: The CADILLAC trial (2003) (0)
Acute Myocardial Infarction The Incidence , Predictors , and Outcomes of Early Reinfarction After Primary Angioplasty for Acute Myocardial Infarction (2016) (0)
COMPARISON OF LONG TERM CLINICAL PROGNOSIS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO THE PRESENCE OF IN-HOSPITAL MAJOR BLEEDING EVENTS: 3 YEAR FOLLOW-UP RESULT OF HORIZONS-AMI (2011) (0)
Systems of Care (2020) (0)
Suboptimal platelet inhibition with tirofiban in patients undergoing coronary intervention for unstable angina (2002) (0)
How to Organize Networks for Invasive Treatment of STEMI: Experience in the United States (2010) (0)
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease (2023) (0)
Essentials of Cardiovascular Medicine (1994) (0)
IMPACT OF HIGH DOSE ASPIRIN IN MEN VS. WOMEN AFTER ACUTE MYOCARDIAL INFARCTION: RESULTS FROM THE HORIZONS-AMI TRIAL (2012) (0)
Long term patency and incidence of restenosis after primary angioplasty therapy of acute myocardial infarction (1991) (0)
VIRTUAL: Featured Clinical Research (2020) (0)
mpact of Intravenous Beta-Blockade efore Primary Angioplasty on Survival n Patients Undergoing Mechanical eperfusion Therapy for Acute Myocardial Infarction (2016) (0)
ST-segment elevation resolution as a predictor of mortality in patients with thrombolysis in myocardial infarction III flow in the infarct artery after primary angioplasty: The CADILLAC trial (2003) (0)
TRENDS IN UPTAKE AND IN-HOSPITAL OUTCOMES WITH 2ND GENERATION DRUG ELUTING STENTS BETWEEN MEN AND WOMEN UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: RESULTS FROM THE CATHPCI REGISTRY (2014) (0)
Spontaneous of infarct stenosis after thrombolysis for acute myocardial infarction is associated with enhanced improvement in left ventricular wall motion (1990) (0)
Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction ☆ (2002) (0)
Should we be less reactive about contrast reaction prophylaxis? (2021) (0)
Developing New Interventional Onco-Cardiology Practices (2019) (0)
A prolonged intracoronary infusion of urokinase for chronic total occlusions: case reviews. (1995) (0)
Will the TRANSFORM II trial transform our management of small vessel coronary disease? (2022) (0)
956-116 The Reperfusion Strategy Does Affect Outcome When Nonsmokers Present with Acute Myocardial Infarction: A PAMI Substudy (1995) (0)
The year in interventional cardiology. (2005) (0)
P5518Axillary artery as alternative access for mechanical circulatory support devices in patients with prohibitive peripheral arterial disease (2018) (0)
Predictors and sequalae of subacute thrombosis after percutaneous intervention in acute myocardial infarction: The CADILLAC trial (2003) (0)
The Role of Thrombolytic Therapy in the Era of STEMI Interventions (2017) (0)
TCT-551 Lactate Clearance is a Prognostic Marker for Survival in Cardiogenic Shock Receiving Early Percutaneous Mechanical Circulatory Support (2017) (0)
The percutaneous coronary intervention patient (2011) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Cindy Lee Grines?

Cindy Lee Grines is affiliated with the following schools:

Ohio State University
University of Michigan
Medical University of South Carolina
Wayne State University
United States Military Academy
Columbia University
University of Arkansas

Cindy Lee Grines's Academic­Influence.com Rankings

Cindy Lee Grines's Degrees

Why Is Cindy Lee Grines Influential?

Cindy Lee Grines's Published Works

Published Works

What Schools Are Affiliated With Cindy Lee Grines?

Cindy Lee Grines's AcademicInfluence.com Rankings